Delivery Order SPE2DB24D1021-SPE2DB25FFAJY
- Not listed
- The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This non-set-aside, firm fixed-price contract represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a $31,982.02 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $36,954.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 22, 2025, is performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,898.82 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract was awarded to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, which serves as the place of performance, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $92,395.87 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's established pharmaceutical distribution...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $134,559.71 on August 13, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $102,913.01 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, reflecting open competition for this pharmaceutical supply requirement. Performance will be executed from...
- The Defense Logistics Agency awarded a $33,897.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $42,594.51 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-count units. The delivery order, which is expected to be completed by July 29, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $18,577.92, with an ultimate completion date of August 15, 2025. The contract is non-set-aside and represents a competitive award under the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAJYDelivery Order
The Defense Logistics Agency awarded a $22,405.18 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and other federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a broad range of medications and medical commodities to support military and veteran healthcare programs. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical needs through competitive procurement processes. As a prime contractor under the DLA pharmaceutical vendor program, AmerisourceBergen supports multiple therapeutic domains and federal customers, positioning it as a key supplier within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 9/8/25 |